AntoXa is using the vivoXPRESS® system to produce an innovator antibody (PhD9) being studied by Defence Research and Development Canada (DRDC) as an antidote to ricin exposure.
Life-saving biodefense solutions
We’re developing safe, effective drugs to combat bioterrorism and infectious disease.
High-quality plant-based pharmaceuticals
Our versatile, scalable platform is ideal for novel indications and new markets.